Medical and surgical treatment outcomes in patients with chronic rhinosinusitis and immunodeficiency: a systematic review

ConclusionPatients with CRS and immunodeficiency likely benefit from ESS based on the available evidence. Data supporting medical therapy in this targeted population is limited overall, but there may be a potential role for immunoglobulin therapy in patients with PID and CRS.

Source: International Forum of Allergy and Rhinology - July 14, 2020 Category: Allergy & Immunology Authors: Shireen Samargandy, Elysia Grose, Yvonne Chan, Eric Monteiro, John M. Lee, Jonathan Yip Tags: ORIGINAL ARTICLE Source Type: research